Ben Arye Barak - 30 Jun 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
General Counsel
Signature
Steven Robbins, as attorney in fact for Ben Arye, Barak
Issuer symbol
NVCR
Transactions as of
30 Jun 2023
Transactions value $
$10,161
Form type
4
Filing time
06 Jul 2023, 16:13:47 UTC
Previous filing
02 Mar 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $10.2K +288 +0.83% $35.28 35.2K 30 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023.